Elite Pharmaceuticals, Inc. (OTCQB: ELTP) has announced that it will release its financial results for the second quarter of fiscal year 2027 on Thursday, November 12, 2026. The company will follow up with a live conference call on Friday, November 13, 2026, at 11:30 AM Eastern Time to discuss these results and provide a general business update.
The conference call is open to stockholders, who are invited to submit questions in advance. General questions must be submitted by 2:00 PM EST on November 12, while financial questions must be submitted by 7:00 PM EST on the same day.
Details for the call are as follows:
- Date: November 13, 2026
- Time: 11:30 AM EST
- Dial-in Numbers: 1-800-346-7359 (domestic) or 1-973-528-0008 (international)
- Conference Number: 98840
- Questions: dianne@elitepharma.com
Elite Pharmaceuticals is a specialty pharmaceutical company that develops and distributes niche generic products. The company specializes in oral, controlled-release drug products and operates a cGMP and DEA-registered research, development, and manufacturing facility in Northvale, New Jersey.